Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Public availability of evidence-based mental health apps: a systematic review and meta-analysis of self-guided apps

AI Summary
  • Fifty two percent of evaluated self guided mental health apps were publicly available.
  • Available apps were most commonly on both Apple App and Google Play Stores, with 40% offered at no cost.
  • Study quality and meta analytic effect size showed no significant association with app availability, indicating a gap between evidence and translation.
Summarise with AI (MRCPsych/FRANZCP)

NPJ Digit Med. 2026 Jul 16. doi: 10.1038/s41746-026-03014-5. Online ahead of print.

ABSTRACT

Despite mental health apps having a rigorous evidence base, little is known about the proportion of efficacious apps that are publicly available. Our systematic review and meta-analysis identified self-guided mental health apps evaluated in controlled trials, determined their public availability, and examined how evidence quality and strength influence availability. A literature search identified 16,971 records, of which 110 studies, investigating 112 apps, met inclusion criteria. Of the 81 unique self-guided apps, 42 (52%) were publicly available. Apps were most commonly available through both Apple App and Google Play Stores (79%) at no cost (40%). Study quality assessed using Cochrane Risk of Bias 2 tool had no significant association with app availability (p = 0.851). Meta-analysis found no significant difference (p = 0.228) in effect size compared to control between available apps (g = 0.33) and unavailable apps (g = 0.45). Considerations apart from evidence quality or strength determine app translation highlighting a gap between evidence and availability.

PMID:42463537 | DOI:10.1038/s41746-026-03014-5

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review